Jaguar health appoints industry veteran to head sales for company's commercialized oncology and hiv products including october 2024 launch of gelclair for cancer supportive care

Fda-approved gelclair ® is company's third commercialized prescription product susan krizancic appointed to role of national sales director at jaguar family company napo pharmaceuticals san francisco, ca / accesswire / september 10, 2024 / jaguar health, inc. (nasdaq:jagx) ("jaguar") today announced that it has appointed biopharmaceutical industry veteran susan krizancic to the role of national sales director for jaguar family company napo pharmaceuticals. "sue is a dynamic and proven commercial leader with 30 years of experience in the biopharmaceuticals industry - including 15 years of recent experience in the oncology market - building high-performing teams and exceeding sales targets.
JAGX Ratings Summary
JAGX Quant Ranking